ArticleJournal of hematology & oncology2019

Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience.

Kamal Chamoun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.